Last reviewed · How we verify

NCT05298826

Recombinant Factor VII for Intractable Postpartum Haemorrhage

Completed Last updated 28 March 2022
What this trial tests

trial testing recombinant factor VIIa in Post Partum Hemorrhage in 41 participants. Completed in 10 January 2020.

Timeline
1 June 2019
Primary endpoint
1 January 2020
10 January 2020

Quick facts

Lead sponsorAljazeera Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment41
Start date1 June 2019
Primary completion1 January 2020
Estimated completion10 January 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Aljazeera Hospital

Who can join

Adults 18 to 45, female only, with Post Partum Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postpartum haemorrhage remains at the top of the causes of maternal deaths in both developed and developing countries .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Post Partum Hemorrhage

Currently open trials in the same condition.

Other Aljazeera Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05298826.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing